Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.41 -0.01 (-0.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Tax Provisions (2021 - 2022)

Updated

Cartesian Therapeutics (RNAC) posted Tax Provisions of -$9.2 million for FY2025, compared with $300,000 in FY2024.

Analysis

Cartesian Therapeutics (RNAC) Tax Provisions (2021 - 2022) Analysis & Trends

Since FY2021, Cartesian Therapeutics has reported Tax Provisions for 5 years.

  • Annual Tax Provisions has run from a low of -$19 million in FY2023 to a high of $15.97 million in FY2021 over five years.
  • Business Quant data shows RNAC's Tax Provisions at $300,000 in FY2024, -$19 million in FY2023, -$609,000 in FY2022 and $15.97 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -176.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 662.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 291.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 242.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -407.00 Mn
10 Cartesian Therapeutics 188.59 Mn -346.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -288,000.00
Sep 30, 2022 -321,000.00
Dec 31, 2021 138,000.00
Sep 30, 2021 15.83 Mn
API Access

Cartesian Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RNAC&period=max&api_key=YOUR_API_KEY